2017 Publications supported by the Fungal Infection Trust directly or indirectly

Pegorie M, Denning DW, Welfare W. Estimating the burden of invasive and serious fungal disease in the UK. J Infect 2017;74:60-71.

Denning DW, Perlin DS, Muldoon EG, Colombo AL, Chakrabarti A, Richardson MD, Sorrell TC. Delivering on the antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis 2017;23:177-183.

Bustamante B, Denning DW, Campos PE. Estimating the burden of fungal infections in the Peruvian population. Eur J Clin Microbiol Infect Dis 2017;36:943-8.

Zaki SM, Denning DW. The burden of serious fungal diseases in Egypt. Eur J Clin Microbiol Infect Dis 2017;36:971-86.

Dufresne SF, Sheppard DC, Cole DC, Denning DC. Estimating the burden of serious fungal diseases in Canada. Eur J Clin Microbiol Infect Dis 2017;36:987-92.

Chayakulkeeree M, Denning DW. Estimating the burden of serious fungal diseases in Thailand. Eur J Clin Microbiol Infect Dis 2017;36:931-5.

Jabeen K, Farooqi J, Mirza M, Denning DW, Zafar A. Estimated burden of serious fungal infections in Pakistan. Eur J Clin Microbiol Infect Dis 2017;36:949-56.

Medina N, Samayoa B, Lau-Bonilla D, Denning DW, Herrera R, Mercado D, Guzmán B, Figueroa L, Pérez JC, Arathoon E. Burden of serious fungal infections in Guatemala. Eur J Clin Microbiol Infect Dis 2017;36:965-69.

Denning DW. Calling upon all public health mycologists. (Editorial) Eur J Clin Microbiol Infect Dis 2017;36:923-4.

Lowes D, Al-Shair K, Newton PJ, Morris J, Harris C, Rautemaa-Richardson R, Denning DW. Baseline parameters of survival in chronic pulmonary aspergillosis. Eur Resp J 2017;49:1601062.

Gugnani H, Denning DW, Rahim R, Sadat A, Belal M, Mahbub S. The estimated burden of serious fungal infections in Bangladesh. Eur J Clin Microbiol Infect Dis 2017;36:993-7.

Duarte EA, Denning DW. Estimating the burden of serious fungal infections in Chile. Eur J Clin Microbiol Infect Dis 2017;36:983-6.

Chekiri-Talbi M, Denning DW. Burden of fungal infections in Algeria. Eur J Clin Microbiol Infect Dis 2017;36:999-1004. [French translation in J Mycol Med 2017; 27:139-145]

Huh K, Ha EY, Denning DW, Peck KR. Estimating the burden of fungal disease in Korea. Eur J Clin Microbiol Infect Dis 2017;36:957-63.

Tilavberdiev SA, Denning DW, Klimko NN. Serious fungal diseases in the Republic of Uzbekistan. Eur J Clin Microbiol Infect Dis 2017;36:925-929.

Zurita J, Denning DW, Paz-Y-Miño A, Solís MB, Arias LM. Serious fungal infections in Ecuador. Eur J Clin Microbiol Infect Dis 2017;36:975-981.

Batac MCR, Denning D. Serious fungal infections in the Philippines. Eur J Clin Microbiol Infect Dis 2017;36:937-941.

Sabino R, Verissímo C, Brandão J, Martins C, Alves D, Pais C, Denning DW. Serious fungal infections in Portugal. Eur J Clin Microbiol Infect Dis 2017;36:1345-1352.

McCarthy MW, Denning DW, Walsh TJ. Future research priorities in fungal resistance. J Infect Dis 2017;64:986-7.

Overton NLD, Simpson A, Bowyer P, Denning DW. Genetic susceptibility to severe asthma with fungal sensitisation. Int J Immunogenet 2017;44:93-106.

Oladele R, Bongomin F, Gago S, Denning DW. HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for “Prevention Is Better Than Cure”? J Fungi 2017: 3, 67.

Bongomin F, Harris C, Foden P, Kosmidis C, Denning DW. Innate and adaptive immune defects in chronic pulmonary aspergillosis. J of Fungi 2017;2:26.

Kwizera R, Parkes Ratanshi R, Page ID, Wiltshire CS, Musaazi J, Fehr J, Castelnuovo B, Kambugu A, Denning DW. Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis. BMC Pulm Med 2017;17:149.

Maghrabi F, Denning DW. The management of chronic pulmonary aspergillosis: The UK National Aspergillosis Centre approach. Curr Fungal Infect Rep 2017;11:242-251.

Bongomin F, Gago S, Oladele RO, Denning DW. Global and national prevalence of fungal diseases – Estimate precision. J Fungi 2017; 3:E57.

Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS. Emergence of echinocandin resistance due to a point mutation in the fks1 gene of Aspergillus fumigatus in a patient with chronic pulmonary aspergillosis. Antimicrob Agents Chemother 2017;61:e01277-17.

Moore CB, Novak-Frazer L, Muldoon E, Dunn KW, Masania R, Richardson M, Rautemaa-Richardson R. First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in a UK patient. Int J Antimicrob Agents 2017, 49: 512-514.

Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 2017;17:e383-e392.

Overton N, Gago S, Bowyer P. Immunogenetics of Chronic and Allergic Aspergillosis. In Carvalho A, editor, Immunogenetics of Fungal Diseaes. Springer. 2017. p. 153-171.